Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy

In February 2022, a critically ill patient colonized with a carbapenem-resistant K. pneumoniae producing KPC-3 and VIM-1 carbapenemases was hospitalized for SARS-CoV-2 in the intensive care unit of Policlinico Umberto I hospital in Rome, Italy. During 95 days of hospitalization, ceftazidime/avibacta...

Descripción completa

Detalles Bibliográficos
Autores principales: Arcari, Gabriele, Cecilia, Federico, Oliva, Alessandra, Polani, Riccardo, Raponi, Giammarco, Sacco, Federica, De Francesco, Alice, Pugliese, Francesco, Carattoli, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617348/
https://www.ncbi.nlm.nih.gov/pubmed/37877547
http://dx.doi.org/10.3201/eid2911.230921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617348/
https://www.ncbi.nlm.nih.gov/pubmed/37877547
http://dx.doi.org/10.3201/eid2911.230921

Ejemplares similares